US Patent 11505610 Compositions and methods comprising anti-NRP2 antibodies
Patent 11505610 was granted and assigned to aTyr Pharma on November, 2022 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11505610 Compositions and methods comprising anti-NRP2 antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
